Z-1584-2013 Class II Terminated

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-1584-2013 was initiated by Roche Diagnostics Operations, Inc. on May 16, 2013 and is designated Class II. Reason for recall: Roche has confirmed the potential for an undetected elevated INR test result with the CoaguChek XS, CoaguChek XS Plus, and CoaguChek XS Pro meters. In rare cases, instead of a value, an ERROR 6… The recall status is terminated (terminated Apr 16, 2014). Affected quantity: 86553 meters.

Recall Details

Product Type
Devices
Report Date
Jul 3, 2013
Initiation Date
May 16, 2013
Termination Date
Apr 16, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
86553 meters

Product Description

CoaguChek XS System (HCP) The CoaguChek XS System is intended for use by professional healthcare providers for quantitative prothrombin time testing for the monitoring of warfarin therapy.

Reason for Recall

Roche has confirmed the potential for an undetected elevated INR test result with the CoaguChek XS, CoaguChek XS Plus, and CoaguChek XS Pro meters. In rare cases, instead of a value, an ERROR 6 message is displayed.

Distribution Pattern

Nationwide Distribution

Code Information

Model/Catalog/Part Number: 04837975001 and 04625412160

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1584-2013
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.